Skip to main content
Log in

Costs lower with cell-based versus egg-based influenza vaccine

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Divino V, et al. A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season. Vaccine : 29 Jul 2020. Available from: URL: http://doi.org/10.1016/j.vaccine.2020.07.023

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs lower with cell-based versus egg-based influenza vaccine. PharmacoEcon Outcomes News 860, 13 (2020). https://doi.org/10.1007/s40274-020-7059-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7059-z

Navigation